DIAGNOSTIC SERVICES
Molecular- Solid Tumor
The Solid Tumor NGS test at Cairo diagnostics analyzes over 1,000 biomarkers across 52 genes. It detects relevant hotspots, SNVs, indels, CNVs, and gene fusions using a single workflow for DNA and RNA. It enables detection of NTRK1, NTRK2, and NTRK3 gene fusion. Includes solid tumor genes for 23 different types of cancer targeted by on-market oncology drugs and published evidence. It contains 7 genes on 43 labels, 15 genes in 19 guidelines and 43 genes in >900 global clinical trials.
Oncomine Focus Gene Panel
Hotspot Genes (35 Genes) | |||
AKT1 | IDH2 | ||
ALK | JAKI | ||
AR | JAK1 | ||
BRAF | JAK2 | ||
CDK4 | JAK3 | ||
CTNNB1 | KIT | ||
DDR2 | KRAS | ||
EGFR | MAP2K1 | ||
ERBB2 | MAP2K2 | ||
ERBB3 | MET | ||
ERBB4 | MTOR | ||
ESR1 | NRAS | ||
FGFR2 | PDGFRA | ||
FGFR3 | PIK3CA | ||
GNA11 | RAF1 | ||
GIVAQ | RET | ||
HRAS | ROS1 | ||
IDH1 | SMO |
Copy Number Genes (19 Genes) | |||
AKT1 | FGFR2 | ||
ALK | FGFR3 | ||
AR | FGFR4 | ||
BRAF | KIT | ||
CCNDI | KRAS | ||
CDK4 | MET | ||
CDK6 | MYC | ||
EGFR | MYCN | ||
ERBB2 | PDGFRA | ||
FGFR1 | PIK3CA |
Gene Fusions (23 Genes) | |||
ABL1 | FGFR2 | ||
AKT3 | FGFR3 | ||
ALK | MET | ||
AXL | NTRK1 | ||
BRAF | NTRK2 | ||
EGER | NTRK3 | ||
ERBB2 | PDGFRA | ||
ERG | PPARG | ||
ETV1 | RAF1 | ||
ETV4 | RET | ||
ETV5 | ROS1 | ||
FGFR1 |
Tumor Specific Panels
Colorectal Panel (14 Genes) | |||||||
AKT1 | BRAF | EGFR | ERBB2 | ERBB4 | FGFR2 | ||
FGFR3 | HRAS | KRAS | MET | MAP2K1 | NRAS | ||
NTRK1 | PIK3CA |
Gynecologic Panel (12 Genes) | |||||||
AKT1 | BRAF | AR | EGFR | ERBB2 | ESR1 | ||
FGFR1 | FGFR2 | KRAS | MYC | NTRK1 | PIK3CA |
Melanoma Panel (12 Genes) | ||||||||
BRAF | CDK4 | CTNNB1 | GNA11 | GNAQ | KIT | MAP2K1 | ||
NRAS | NTRK1 | PDGFRA | PIK3CA | SMO |
Lung Panel (13 Genes) | ||||||||||
ATK1 | ALK | BRAF | DDR2 | EGFR | ERBB2 | FGFR1 | KRAS | MAP2K1 | ||
MET | NRAS | NTRK1 | PIK3CA |
Urologic Panel (12 Genes) | |||||||
AR | ERG | ETV1 | ETV4 | MYC | NTRK1 | ||
PALB2 |